National Center for Geriatrics and Gerontology

Obu-shi, Aichi-ken 474-8511

0 studies enrolling now · 3 studies all time

What they study most

Alzheimer's Disease, Dyslipidemia, Early Preclinical Alzheimer's Disease, Preclinical Alzheimer's Disease, Type2 Diabetes

Studies at this site

• AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid — Running, not enrolling
• Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) — Stopped early
• A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease — Stopped early